SCHEMBL4897627

SCHEMBL4897627

CCN(c1ccc(OCc2ccc(F)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 6/20 0.48
NFE2L2 Q16236 6/20 0.48
LMNA P02545 1/20 0.47
MMP9 P14780 2/20 0.46
MMP2 P08253 1/20 0.46
NR4A2 P43354 1/20 0.45
KMT2A Q03164 2/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PPARA Q07869 2/20 0.43
MAOB P27338 3/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
MMP13 P45452 1/20 0.41
ADAM17 P78536 1/20 0.41
MAOA P21397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906732 0.92 LMNA (0.47) KEAP1NFE2L2LMNAMMP9MMP2
SCHEMBL4904039 0.91 KEAP1 (0.47) KEAP1NFE2L2LMNAMMP9MMP2
SCHEMBL4906496 0.91 LMNA (0.51) KEAP1NFE2L2LMNAMMP9KMT2A
SCHEMBL4897727 0.90 MMP2 (0.48) KEAP1NFE2L2LMNAMMP9MMP2
SCHEMBL4897482 0.89 LMNA (0.53) KEAP1NFE2L2LMNAMMP9MMP2
SCHEMBL4906264 0.89 LMNA (0.52) LMNAKMT2ATSHRMAPK1HSD17B10
SCHEMBL4907113 0.85 LMNA (0.53) KEAP1NFE2L2LMNAMMP9MMP2
SCHEMBL4907012 0.83 LMNA (0.49) KEAP1NFE2L2LMNAKMT2ATSHR
SCHEMBL4908025 0.83 MMP9 (0.42) KEAP1NFE2L2LMNAMMP9MMP2
SCHEMBL4894515 0.83 LMNA (0.45) KEAP1NFE2L2LMNAMMP9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KEAP1 810/4885NFE2L2 446/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KEAP1 810/4885NFE2L2 446/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.